Author:
Zegers Amber Daniëlle,Coenen Pieter,Heeren Amy,Takke Nadia,Ardon Hilko,Compter Annette,Dona Desiree,Kouwenhoven Mathilde,Schagen Sanne B.,de Vos Filip,Duijts Saskia F. A.
Abstract
Abstract
Purpose
Many patients with a malignant (i.e., grade II-IV) glioma are of working age, yet they are rarely included in “cancer and work” studies. Here, we explored (1) the work-related experiences and unmet needs of patients with a malignant glioma and (2) the experiences and needs of relevant healthcare and occupational (health) professionals (“professionals”) in providing work-related support to this patient group.
Methods
Individual semi-structured interviews were held with patients with a malignant glioma who were of working age and had an employment contract at diagnosis, and relevant professionals. Interviews were transcribed verbatim and analysed thematically.
Results
Patients (n = 22) were on average 46 ± 13 years of age (64% male) and diagnosed with a grade II (n = 12), III (n = 4), or IV glioma (n = 6). Professionals (n = 16) had on average 15 ± 9 years of relevant work experience with the patient group. Four themes emerged from the data: (1) having a malignant glioma: experienced consequences on work ability, (2) communicating about the consequences of a malignant glioma at work, (3) distilling the right approach: generic or tailored work-related support, and (4) accessibility of work-related support.
Conclusions
Glioma-specific consequences on patients’ work ability necessitate better communication between, and tailored guidance for, patients, relevant professionals, and the workplace. Suggestions for improvement, e.g., the periodic use of comprehensive neuropsychological assessments, are provided in the article.
Implications for cancer survivors
Patients with a malignant glioma would benefit from tailored and proactive outreach about work-related issues bv relevant professionals.
Publisher
Springer Science and Business Media LLC
Subject
Oncology (nursing),Oncology
Reference52 articles.
1. Goodenberger ML, Jenkins RB. Genetics of adult glioma. Cancer Genet. 2012;205(12):613–21.
2. Netherlands Comprehensive Cancer Organisation. Overleving hersentumoren [Prognosis of brain tumors]. n.d. https://iknl.nl/kankersoorten/hersentumoren/registratie/overleving. Accessed 24 April 2023.
3. Netherlands Comprehensive Cancer Organisation. Incidentie hersentumoren (Incidence of brain tumours). n.d. https://iknl.nl/kankersoorten/hersentumoren/registratie/incidentie. Accessed 24 April 2023.
4. Netherlands Comprehensive Cancer Organisation. Hersentumoren [Brain tumors]. n.d. https://iknl.nl/kankersoorten/hersentumoren. Accessed 24 April 2023.
5. Ho VK, Reijneveld JC, Enting RH, Bienfait HP, Robe P, Baumert BG, et al. Changing incidence and improved survival of gliomas. Eur J Cancer. 2014;50(13):2309–18.
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献